Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea. 1984

H C Korting, and M Schäfer-Korting, and R Haag, and E Mutschler

Following a single intramuscular application of 1 g ceftizoxime, levels of the drug were determined in plasma as well as in suction blister fluid (SBF) and cantharides blister fluid (CBF). This regimen invariably led to both high and long-lasting plasma levels: 81 +/- 16 min post dose maximum plasma levels of 17.5 +/- 3.1 micrograms/ml were reached; 6 h post dose levels of 4.6 +/- 0.4 micrograms/ml were still found, i.e., 4375 and 1150 times, respectively, the MIC90% of Neisseria gonorrhoeae. The high plasma levels were parallelled by high concentrations in SBF, with peaks amounting to 8.4 +/- 1.0 micrograms/ml. Peak concentrations in CBF ranged from 8.1 to 15.7 micrograms/ml. Thus, the pharmacokinetic behavior of ceftizoxime given as a single intramuscular injection of 1 g explained the excellent clinical results of this regimen in uncomplicated gonorrhea.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008297 Male Males
D001768 Blister Visible accumulations of fluid within or beneath the epidermis. Bulla,Vesication,Bleb,Bullae,Bullous Lesion,Blebs,Blisters,Bullous Lesions,Lesion, Bullous,Lesions, Bullous,Vesications
D002193 Cantharidin A toxic compound, isolated from the Spanish fly or blistering beetle (Lytta (Cantharis) vesicatoria) and other insects. It is a potent and specific inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). This compound can produce severe skin inflammation, and is extremely toxic if ingested orally. Cantharides,Cantharidine
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006069 Gonorrhea Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879. Neisseria gonorrhoeae Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H C Korting, and M Schäfer-Korting, and R Haag, and E Mutschler
January 1958, Deutsches Archiv fur klinische Medizin,
H C Korting, and M Schäfer-Korting, and R Haag, and E Mutschler
April 1952, Bollettino della Societa italiana di biologia sperimentale,
H C Korting, and M Schäfer-Korting, and R Haag, and E Mutschler
January 1991, Skin pharmacology : the official journal of the Skin Pharmacology Society,
H C Korting, and M Schäfer-Korting, and R Haag, and E Mutschler
January 1950, Annali italiani di dermatologia e sifilografia,
H C Korting, and M Schäfer-Korting, and R Haag, and E Mutschler
January 1982, Archives of dermatological research,
H C Korting, and M Schäfer-Korting, and R Haag, and E Mutschler
August 2000, Journal of chemotherapy (Florence, Italy),
H C Korting, and M Schäfer-Korting, and R Haag, and E Mutschler
August 2019, Lipids in health and disease,
H C Korting, and M Schäfer-Korting, and R Haag, and E Mutschler
January 2020, Frontiers in immunology,
H C Korting, and M Schäfer-Korting, and R Haag, and E Mutschler
July 1991, The British journal of dermatology,
H C Korting, and M Schäfer-Korting, and R Haag, and E Mutschler
October 2007, Proteomics,
Copied contents to your clipboard!